Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Pierre Laurin, CEO, ProMetic Life Sciences Inc
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Pierre Laurin of ProMetic gives a summary of the company's drug development platform
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Championing D&I: Insights from Workplace Leaders | Eric Born - Chief Executive Officer of Grafton Group
00:10:00
Sponsor Spotlight: Stephanie Mackara, Principal Wealth Advisor at Charleston Investment Advisors
00:00:00
Isaac Kohane, MD, PhD Chair of the Department of Biomedical Informatics, Harvard Medical School | Artificial Intelligence and NEJM AI
00:10:00
Closing the deal is just the beginning|Jim Southern,Founding Partner,Pacific Lake Partners
00:10:00
Padtec's Business Model Unveiled by CEO Carlos Raimar | Carlos Raimar, CEO, Padtec Holding S.A.
00:10:00
Navigating COVID-19 and Expanding Horizons: Aritzia CEO Brian Hill's Vision | Brian Hill, CEO, Aritzia.
00:10:00
Mr. CEO Unveils Embraer's New Turboprop with 250+ LOIs | Arjan Meijer - CEO of Embraer
00:10:00
Zhang Yichen on Chinese Economy: State Control's Economic Impact | Yichen Zhang, CEO , CITIC Capital Holding.
00:10:00
Strategic Expansion and Strong Financial Outlook at UniCredit | Andrea Orcel, CEO , UniCredit .
00:10:00
Navigating the Future of Business Intelligence: Insights from OBASE CEO Dr. Bülent Dal | Dr. Bülent Dal, CEO, Obase Bilgisayar ve Danışmanlık Hizmetleri.
00:10:00
The GO Foundation South Australia launches on Friday, February 15, at the Adelaide Fringe Festival along the Torrens River.
00:10:00
Navigating Yield Sustainability in Australian Healthcare Property Investments| David Burgess, Co-Head , Elanor Commercial Property Fund.